Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire.
Few studies have examined the subjective value attributed to drug rewards specifically as it compares with the value attributed to primary non-drug rewards in addicted individuals. The objective of this study is to assess 'liking' and 'wanting' of expected 'drug' rewards as compared to 'food' and 'sex' while respondents report about three different situations ('current', and hypothetical 'in general', and 'under drug influence'). In all, 20 cocaine-addicted individuals (mean abstinence = 2 days) and 20 healthy control subjects were administered the STRAP-R (Sensitivity To Reinforcement of Addictive and other Primary Rewards) questionnaire after receiving an oral dose of the dopamine agonist methylphenidate (20 mg) or placebo. The reinforcers' relative value changed within the addicted sample when reporting about the 'under drug influence' situation (drug > food; otherwise, drug < food). This change was highest in the addicted individuals with the youngest age of cocaine use onset. Moreover, 'drug' 'wanting' exceeded 'drug' 'liking' in the addicted subjects when reporting about this situation during methylphenidate. Thus, cocaine-addicted individuals assign the highest subjective valence to 'drug' rewards but only when recalling cue-related situations. When recalling this situation, they also report higher 'drug' 'wanting' than hedonic 'liking', a motivational shift that was only significant during methylphenidate. Together, these valence shifts may underlie compulsive stimulant abuse upon pharmacological or behavioural cue exposure in addicted individuals. Additional studies are required to assess the reliability of the STRAP-R in larger samples and to examine its validity in measuring the subjective value attributed to experienced reinforcers or in predicting behaviour.
Goldstein
R Z
RZ
Department of Medical Research, Center for Translational Neuroimaging, Brookhaven National Laboratory, Upton, NY 11973-5000, USA. rgoldstein@bnl.gov
Woicik
P A
PA
Moeller
S J
SJ
Telang
F
F
Jayne
M
M
Wong
C
C
Wang
G J
GJ
Fowler
J S
JS
Volkow
N D
ND
D000328:Adult; D017668:Age of Onset; D016739:Behavior, Addictive / Q000523:psychology*; D016022:Case-Control Studies; D019970:Cocaine-Related Disorders / Q000523:psychology*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology; D008875:Middle Aged; D009042:Motivation; D011594:Psychometrics; D012201:Reward; D011795:Surveys and Questionnaires
D018765:Dopamine Uptake Inhibitors; D008774:Methylphenidate
Addiction. 1999 Mar;94(3):327-40
10605857
Addiction. 2001 Jan;96(1):103-14
11177523
J Am Med Assoc. 1955 Mar 19;157(12):1006-20
14353639
Neuropsychologia. 2002;40(10):1690-705
11992657
Science. 1991 Mar 29;251(5001):1580-6
2011738
J Neurosci. 2003 Feb 1;23(3):742-7
12574402
Psychopharmacology (Berl). 1999 Feb;142(1):31-40
10102780
Psychopharmacology (Berl). 1999 Feb;142(2):200-8
10102773
J Neurosci. 2006 Jun 14;26(24):6583-8
16775146
Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
12402102
Nature. 1997 Apr 24;386(6627):827-30
9126740
J Pharmacol Exp Ther. 1985 Dec;235(3):677-82
4078729
Annu Rev Psychol. 2003;54:25-53
12185211
Exp Clin Psychopharmacol. 1997 Aug;5(3):256-62
9260073
Behav Neurosci. 2005 Dec;119(6):1619-27
16420164
Physiol Behav. 2007 Jan 30;90(1):36-42
17052736
J Am Med Assoc. 1955 Mar 26;157(13):1113-9
14353650
Am J Psychiatry. 2000 Nov;157(11):1789-98
11058476
J Neurosci. 2001 Oct 1;21(19):7831-40
11567074
Behav Neurosci. 2002 Apr;116(2):321-33
11996317
Am J Psychiatry. 2004 Jul;161(7):1173-80
15229048
J Neurosci. 2006 May 31;26(22):5881-7
16738229
Psychopharmacology (Berl). 2000 Oct;152(2):140-8
11057517
Am J Psychiatry. 1998 Oct;155(10):1325-31
9766762
Am J Psychiatry. 1999 Jan;156(1):19-26
9892293
Addiction. 2006 May;101(5):713-25
16669905
Psychopharmacology (Berl). 1992;107(4):523-9
1603895
Am J Psychiatry. 2002 Oct;159(10):1642-52
12359667
Am J Psychiatry. 1999 Sep;156(9):1440-3
10484959
J Stud Alcohol. 1994 Mar;55(2):224-9
8189743
Addict Behav. 1992 Sep-Oct;17(5):491-9
1332435
Arch Gen Psychiatry. 2002 Dec;59(12):1162-72
12470133
NIDA Res Monogr. 1993;135:15-30
8289894
J Neurosci. 2003 Dec 10;23(36):11461-8
14673011
Behav Brain Res. 2002 Jan 22;128(2):189-203
11796164
Synapse. 2002 Jun 1;44(3):175-80
11954049
Addiction. 2005 Oct;100(10):1487-95
16185210
J Subst Abuse Treat. 1994 Nov-Dec;11(6):549-52
7884838
Nat Neurosci. 2002 Jul;5(7):625-6
12055635
Psychopharmacology (Berl). 2005 Apr;178(4):493-9
15517194
J Neurosci. 1999 Jan 1;19(1):456-63
9870973
Pharmacol Biochem Behav. 2005 Sep;82(1):90-7
16112720
Drug Alcohol Depend. 2007 Mar 16;87(2-3):233-40
16997508
Science. 1998 Oct 9;282(5387):298-300
9765157
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
8401595
Psychoneuroendocrinology. 2005 Oct;30(9):880-91
15975729
Drug Alcohol Depend. 1997 Mar 14;44(2-3):87-94
9088780